The market hasn't missed this one...it's too good a deal in the stem cell space. The big volume on the day the announcement was released confirms this. The fact it didnt run up and has ended up down on very positive news is very indicative of capping. Which isnt surprising given the deal. Big players want a piece if this. They've got this 50c/share figure in their heads also. Once they've accumulated enough it will run.
RGS Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
